ืื‘ืจื•ื ื™ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” (ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื•ืŸ ื‘ื™ื—ื™ื“) ื”ื "ืชื—ื ืช ื”ื›ื•ื—", ืคืฉื•ื˜ื• ื›ืžืฉืžืขื•, ืฉืœ ื›ืœ ื”ืื•ืจื’ื ื™ื–ืžื™ื. ืžื“ื•ื‘ืจ ื‘“ืชืื™ื” ื‘ืชื•ืš ืชืื™ื, ื•ื‘ืœืขื“ื™ื”ื ืจืžื•ืช ื”ืื ืจื’ื™ื” ื”ื“ืจื•ืฉื•ืช ืœื ื• ืœืชืคืงื•ื“ ืชืงื™ืŸ ื™ืฆื ื—ื• ื‘ืžื”ื™ืจื•ืช. ืื‘ืจื•ื ื™ ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ืžืฆื•ื™ื™ื ื‘ื›ืœ ืชื ื‘ื’ื•ืฃ ื”ืื“ื, ืœืžืขื˜ ื‘ืชืื™ ื”ื“ื ื”ืื“ื•ืžื™ื— ื‘ืชื ืžืžื•ืฆืข ื™ืฉ ื›-1,000 ืื‘ืจื•ื ื™ ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ื”ืžื™ื™ืฆืจื™ื ืื ืจื’ื™ื” ื‘ืชื•ืš ื“ืคื ื•ืชื™ื•, ื•ื‘ืชืื™ ืฉืจื™ืจ ื”ืœื‘ ื›-5,000 ื›ืืœื•. 

ืื‘ืจื•ื ื™ ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ื‘ืจื™ืื™ื ื•ืžืชืคืงื“ื™ื ื”ื ื›ืžื• ืกื•ืœืœื” ืžืœืื” ื‘ื˜ืœืคื•ืŸ ืฉืœื›ื. ืžืžืฉ ื›ืคื™ ืฉืชืฉืชืžืฉื• ืคื—ื•ืช ื‘ื˜ืœืคื•ืŸ ืฉืœื›ื ื›ืืฉืจ ื”ืกื•ืœืœื” ืžืชืจื•ืงื ืช ื•ืื™ืŸ ืœื›ื ืื™ืš ืœื˜ืขื•ืŸ ืื•ืชื” ืžื—ื“ืฉ, ื›ืš ื’ื•ืคื›ื ื™ืฉืชืžืฉ ื‘ืคื—ื•ืช ืื ืจื’ื™ื” ื›ื›ืœ ืฉื”ื™ื ืžืชืจื•ืงื ืช ื™ื•ืชืจ, ื•ืืชื ืขืœื•ืœื™ื ืœื”ืจื’ื™ืฉ ืขื™ื™ืคื•ืช ื•ื›ืื‘ื™ ืฉืจื™ืจื™ื. 

ื”ืžื“ืข ืžืื—ื•ืจื™ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”

ื”ืžื˜ืจื” ื”ืขื™ืงืจื™ืช ืฉืœ ืื‘ืจื•ื ื™ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ื”ื™ื ืœืงื—ืช ื’ืœื•ืงื•ื– ืื• ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ, ื™ื—ื“ ืขื ื”ื—ืžืฆืŸ ืฉืื ื• ื ื•ืฉืžื™ื, ื•ืœื”ืžื™ืจ ืื•ืชื ืœืื ืจื’ื™ื”. ืœืฉื ื›ืš ื ื“ืจืฉืช ื›ืžื•ืช ืžืชืื™ืžื” ืฉืœ ื•ื™ื˜ืžื™ื ื™ื, ืžื™ื ืจืœื™ื, ื•ื—ื•ืžืจื™ื ืžื–ื™ื ื™ื ื ื•ืกืคื™ื ืขืœื™ื”ื ื ืกื‘ื™ืจ ื‘ื”ืžืฉืš. ื”ืคืงืช ืื ืจื’ื™ื” ืžืชืจื—ืฉืช ื‘ื›ืœ ืฉื ื™ื™ื” ื‘ื™ื•ื, ื‘ื™ืŸ ืื ืื ื• ืขืจื™ื ืื• ื™ืฉื ื™ื. 

ื™ื—ืกื™ืช ืœืžืฉืงืœื ื‘ื’ืจืžื™ื, ืื‘ืจื•ื ื™ ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ืžื™ื™ืฆืจื™ื ื™ื•ืชืจ ืื ืจื’ื™ื” ืžืืฉืจ ื”ืฉืžืฉ, ืžื” ืฉื”ื•ืคืš ืื•ืชื ืœืžื‘ื ื™ื ื”ื™ืฆืจื ื™ื™ื ื”ื—ื–ืงื™ื ื‘ื™ื•ืชืจ ื‘ื™ืงื•ื. ืœืื—ืจ ืฉื’ืœื•ืงื•ื– ืื• ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ืขื•ื‘ืจื™ื ืฉื™ื ื•ื™ื™ื ื‘ื™ื•ื›ื™ืžื™ื™ื, ืื‘ืจื•ื ื™ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ืžืฉื ืขื™ื ืืช ื”ืืœืงื˜ืจื•ื ื™ื ืฉืœื”ื ื‘ืืžืฆืขื•ืช ืžืขืจื›ืช ืžืงื™ืคื” ื”ื ืงืจืืช ืฉืจืฉืจืช ื”ื•ื‘ืœืช ื”ืืœืงื˜ืจื•ื ื™ื (ETC). ื›ืืŸ ืžืชืจื—ืฉ ื”ืงืกื — ืื‘ืจื•ื ื™ ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ื—ื“ืฉื™ื ื ื•ืฆืจื™ื ื‘ืžื”ืœืš ืื™ืžื•ืŸ ื•ืฆื•ื, ื•ื–ื• ื”ืกื™ื‘ื” ืœื›ืš ืฉืœืขื™ืชื™ื ืงืจื•ื‘ื•ืช ืคืขื™ืœื•ื™ื•ืช ืืœื• ืžืฉืคืจื•ืช ืืช ืจืžื•ืช ื”ืื ืจื’ื™ื” ื”ื›ื•ืœืœืช. 

ื”ืžื•ื— ืฆื•ืจืš 70 ืื—ื•ื–ื™ื ืžืื ืจื’ื™ื™ืช ื”ื’ื•ืฃ, ื•ืœืื—ืจ ืžื›ืŸ ื”ืœื‘, ื”ื›ืœื™ื•ืช, ื”ื›ื‘ื“ ื•ื”ืขื™ื ื™ื™ื. ื–ื” ืžืกื‘ื™ืจ ืžื“ื•ืข ื ืจืื” ืฉืœืชืคืงื•ื“ ืœืงื•ื™ ืฉืœ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ื™ืฉ ืงืฉืจ ืœืžืฆื‘ื™ื ื”ืจืคื•ืื™ื™ื ื”ื‘ืื™ื: 

  • ืื•ื‘ื“ืŸ ืฉืžื™ืขื” ื”ืงืฉื•ืจ ืœื’ื™ืœ
  • ืขื™ื™ืคื•ืช ื›ืจื•ื ื™ืช (ืžื—ืกื•ืจ ื‘ืื ืจื’ื™ื”)
  • ืื™ ืกืคื™ืงืช ืœื‘
  • ื“ื™ื›ืื•ืŸ
  • ืคื™ื‘ืจื•ืžื™ืืœื’ื™ื” (ืžื™ื—ื•ืฉื™ื ื•ื›ืื‘ื™ื ื‘ืฉืจื™ืจื™ื)
  • ื‘ืจืงื™ืช (ื’ืœืื•ืงื•ืžื”)
  • ืขืงืจื•ืช (ืชืื™ ื”ื–ืจืข ืžืงื‘ืœื™ื ืืช ื”ืื ืจื’ื™ื” ืฉืœื”ื ืžืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”)
  • ื ื™ื•ื•ืŸ ืžืงื•ืœืจื™ 
  • ืคื’ื™ืขื” ื‘ื–ื™ื›ืจื•ืŸ
  • ืžื™ื’ืจื ื•ืช ื•ื›ืื‘ื™ ืจืืฉ
  • ื”ื–ื“ืงื ื•ืช ืžื•ืงื“ืžืช 

ืื•ืจื— ื”ื—ื™ื™ื ืฉืœื ื• ืขืœื•ืœ ืœืคื’ื•ืข ื‘ื™ืขื™ืœื•ืช ืฉืœ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”. ื™ื™ืชื›ืŸ ืฉืชืคืงื•ื“ ืชืงื™ืŸ ืฉืœ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ืงืฉื•ืจ ืœืื•ืจื— ื—ื™ื™ื ืžืื•ื–ืŸ. ื”ืžืฉืžืขื•ืช ื”ื™ื ืฉื™ื ื” ื˜ื•ื‘ื” ื•ืชื–ื•ื ื” ื ื›ื•ื ื” ื•ืžืœืื” ื‘ืชื•ืกืคืช ืžื’ื•ื•ืŸ ืคื™ืจื•ืช ื•ื™ืจืงื•ืช ื›ื“ื™ ืœื”ืขื ื™ืง ืœื’ื•ืฃ ื˜ื•ื•ื— ืจื—ื‘ ืฉืœ ื•ื™ื˜ืžื™ื ื™ื, ืžื™ื ืจืœื™ื ื•ืคื™ื˜ื•ื ื•ื˜ืจื™ืื ื˜ื™ื. ื‘ื ื•ืกืฃ, ื™ืฉ ืœื•ื•ืกืช ื›ืจืื•ื™ ืืช ืจืžื•ืช ื”ืœื—ืฅ ื”ื™ื•ืžื™ื•ืžื™ื•ืช ื›ื“ื™ ืœื”ื‘ื˜ื™ื— ืื™ื–ื•ืŸ ืชืงื™ืŸ ืฉืœ ืžืขืจื›ืช ื”ืขืฆื‘ื™ื ื”ืคื ื™ืžื™ืช. 

ื”ืื ืขืœื™ื›ื ืœืฉืงื•ืœ ื ื˜ื™ืœืช ืชื•ืกืคื™ ืชื–ื•ื ื”?

ื’ื ืื ื”ื›ื•ื•ื ื•ืช ืฉืœื›ื ื˜ื•ื‘ื•ืช ื•ืืชื ืขื•ืฉื™ื ืืช ืžืจื‘ ื”ืžืืžืฆื™ื ืœืฉื ื›ืš, ืœื ืงืœ ืœื”ื’ื™ืข ืœืžืฆื‘ ืฉืœ ืชื–ื•ื ื” ืžืื•ื–ื ืช ื•ื”ืคื—ืชืช ืœื—ืฅ. ื‘ื”ืชืื ืœื ืกื™ื‘ื•ืช ื”ืื™ืฉื™ื•ืช ื”ื™ื™ื—ื•ื“ื™ื•ืช ืฉืœ ื›ืœ ืื—ื“, ื›ื“ืื™ ืœืฉืงื•ืœ ื ื˜ื™ืœืช ืชื•ืกืคื™ ืชื–ื•ื ื”, ื‘ืžื™ื•ื—ื“ ื›ืืฉืจ ืงื™ื™ืžื™ื ืžืฆื‘ื™ื ื‘ืจื™ืื•ืชื™ื™ื ื›ืจื•ื ื™ื™ื. ืœื“ื•ื’ืžื”, ืกื•ื›ืจืช, ืœื—ืฅ ื“ื ื’ื‘ื•ื”, ืกืจื˜ืŸ ื•ืžื—ืœื•ืช ืขื™ื›ื•ืœ ืขืœื•ืœื™ื ืœื”ื’ื‘ื™ืจ ืืช ื”ื“ืจื™ืฉื•ืช ื”ืžื˜ื‘ื•ืœื™ื•ืช ืœื—ื•ืžืจื™ื ืžื–ื™ื ื™ื ืžืกื•ื™ืžื™ื.

ืžืขื ื™ื™ืŸ ืœืฆื™ื™ืŸ ื›ื™ ืœืื ืฉื™ื ืฉืžืชืขืžืœื™ื ื‘ืื•ืคืŸ ืงื‘ื•ืข ืขืœื•ืœื•ืช ืœื”ื™ื•ืช ืจืžื•ืช ืชื–ื•ื ื” ื ืžื•ื›ื•ืช ืžื”ืจื’ื™ืœ, ื–ืืช ืžื›ื™ื•ื•ืŸ ืฉื—ื•ืžืจื™ื ืžื–ื™ื ื™ื ืจื‘ื™ื ืžื•ืคืจืฉื™ื ื‘ื–ื™ืขื”. ื”ืชื•ืฆืื” ื”ื™ื ื“ืจื™ืฉื•ืช ืชื–ื•ื ืชื™ื•ืช ื’ื‘ื•ื”ื•ืช ืžื”ืžืžื•ืฆืข. ื‘ื ื•ืกืฃ, ื”ื™ื›ื•ืœืช ืฉืœ ื”ืžืขื™ื™ื ืœืกืคื•ื’ ื—ื•ืžืจื™ื ืžื–ื™ื ื™ื ืคื•ื—ืชืช ืžืฉืžืขื•ืชื™ืช ื›ื›ืœ ืฉืื ื• ืžืชื‘ื’ืจื™ื. 

ืชืจื•ืคื•ืช ืœื”ื•ืจื“ืช ื›ื•ืœืกื˜ืจื•ืœ (ืื˜ื•ืจื‘ืกื˜ื˜ื™ืŸ, ืกื™ืžื•ื•ืกื˜ื˜ื™ืŸ ื•ื›ื•'), ื—ื•ืกืžื™ ื‘ื˜ื (ืื˜ื ื•ืœื•ืœ, ืงืจื•ื•ื“ื™ืœื•ืœ, ืžื˜ืจื•ืคื•ืœื•ืœ ื•ื›ื•'), ืžื“ื›ืื™ ื”ืคืจืฉืช ื—ื•ืžืฆื” ืื• ื—ื•ืžืจื™ื ืžืฉืชื ื™ื ืขืœื•ืœื™ื ืœื”ืคืจื™ืข ืœื™ื™ืฆื•ืจ ื•ืœืกืคื™ื’ื” ืฉืœ ืจื‘ื™ื ืžื”ืชื•ืกืคื™ื ืฉืœื”ืœืŸ, ืื• ืœื’ืจื•ื ืœื”ืคืจืฉื” ืžื•ื’ื‘ืจืช ืฉืœื”ื ืžื”ื’ื•ืฃ. 

ืชื•ืกืคื™ ืชื–ื•ื ื” ืœืžื™ื˜ื•ื‘ ื‘ืจื™ืื•ืช ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ื•ื™ื™ืฆื•ืจ ื”ืื ืจื’ื™ื”

ืงื• ืื ื–ื™ื Q10 

CoQ10 ื ื“ืจืฉ ืœืฆื•ืจืš ืชืคืงื•ื“ ืชืงื™ืŸ ืฉืœ ื›ืœ ื”ืชืื™ื ื‘ื’ื•ืฃ. ื‘ื“ืจืš ื›ืœืœ ื™ื™ืฆื•ืจ ื”ืงื• ืื ื–ื™ื 10 ืคื•ื—ืช ืขื ื”ื’ื™ืœ, ื•ืจืžื•ืชื™ื• ื‘ื’ื•ืฃ ืžืชื—ื™ืœื•ืช ืœืจื“ืช ืžื’ื™ืœืื™ 40 ื•ืžืขืœื”. ื‘ื ื•ืกืฃ, ื’ื ืืฆืœ ืื ืฉื™ื ืฉื ื•ื˜ืœื™ื ืชืจื•ืคื•ืช ืกื˜ื˜ื™ื ื™ื•ืช ืœื”ื•ืจื“ืช ืจืžื•ืช ื’ื‘ื•ื”ื•ืช ืฉืœ ื›ื•ืœืกื˜ืจื•ืœ ืื• ืœื˜ื™ืคื•ืœ ื‘ืกื•ื›ืจืช ืงื™ื™ืžืช ื ื˜ื™ื™ื” ืœืจืžื•ืช ื ืžื•ื›ื•ืช ื™ื•ืชืจ ืฉืœ ืงื• ืื ื–ื™ื 10. ืžื™ื ื•ืŸ ืžื•ืžืœืฅ: 50 ืขื“ 300 ืž"ื’ ืœื™ื•ื.

L-ืงืจื ื™ื˜ื™ืŸ 

ื—ื•ืžืฆืช ืืžื™ื ื• ื—ืฉื•ื‘ื” ื–ื• ื ื“ืจืฉืช ืœืฉื ื™ื™ืฆื•ืจ ืื ืจื’ื™ื”. ืชืคืงื™ื“ื” ื”ืขื™ืงืจื™ ื”ื•ื ืœืกื™ื™ืข ื‘ื”ืขื‘ืจืช ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ื—ื•ืคืฉื™ื•ืช ืืœ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”, ืฉื ื ื™ืชืŸ ืœื”ืฉืชืžืฉ ื‘ื”ืŸ ืœื”ืคืงืช ืื ืจื’ื™ื”. ืคืขื•ืœื” ื–ื• ืžืชืจื—ืฉืช ืœืื—ืจ ืฉื—ื•ืžืฆื•ืช ื”ืฉื•ืžืŸ ื”ื—ื•ืคืฉื™ื•ืช ืขื•ื‘ืจื•ืช ืชื”ืœื™ืš ื”ืžื›ื•ื ื” ื‘ื˜ื-ื˜ืจื ืกืคื•ืจืžืฆื™ื”. 

ื’ื•ืฃ ื”ืื“ื ื™ื›ื•ืœ ืœื™ื™ืฆืจ ื‘ืขืฆืžื• L- ืงืจื ื™ื˜ื™ืŸ, ื•ื ื™ืชืŸ ื’ื ืœืฆืจื•ืš ืื•ืชื” ืขืœ ื™ื“ื™ ืื›ื™ืœืช ืžืื›ืœื™ื ืžืกื•ื™ืžื™ื. ืืฆืœ ืฆืžื—ื•ื ื™ื™ื ื•ืงืฉื™ืฉื™ื ืงื™ื™ืžืช ื ื˜ื™ื™ื” ืœืจืžื•ืช ื ืžื•ื›ื•ืช ื™ื•ืชืจ ืฉืœ ื—ื•ืžืฆื” ื–ื• ื‘ื”ืฉื•ื•ืื” ืœืจืžืชื” ืืฆืœ ืื ืฉื™ื ืื•ื›ืœื™ ื›ืœ ืื• ื‘ืงืจื‘ ืฆืขื™ืจื™ื, ื‘ื”ืชืืžื”. ื’ื ืืฆืœ ืื ืฉื™ื ืฉื ื•ื˜ืœื™ื ืชืจื•ืคื•ืช ืžืกื•ื™ืžื•ืช ืœื˜ื™ืคื•ืœ ื‘ืคืจื›ื•ืกื™ื (ื—ื•ืžืฆื” ื•ืœืคืจื•ืื™ืช, ืคื ื•ื•ื‘ืจื‘ื™ื˜ืœ, ืคื ื™ื˜ื•ืื™ืŸ ืื• ืงืจื‘ืžื–ืคื™ืŸ) ืงื™ื™ืžืช ื ื˜ื™ื™ื” ืœืจืžื•ืช ื ืžื•ื›ื•ืช ื™ื•ืชืจ ืฉืœ L-ืงืจื ื™ื˜ื™ืŸ. 

ืžื—ืงืจ ืฉื ืขืจืš ื‘-2002 ื”ืจืื” ืฉื”ื–ื ืช ื—ื•ืœื“ื•ืช ื‘-L-ืงืจื ื™ื˜ื™ืŸ (ื•ื—ื•ืžืฆื” ืืœืคื ืœื™ืคื•ืื™ืช), ืžืฉืคืจืช ืืช ืชืคืงื•ื“ื ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ืืœื™ ื•ืžืคื—ื™ืชื” ืขืงื” ื—ืžืฆื•ื ื™ืช. ืžื—ืงืจ ื ื•ืกืฃ ืฉื ืขืจืš ื‘ืฉื ืช 2002 ื“ืŸ ื‘ืชื•ืขืœื•ืช ืฉืœ L-ืงืจื ื™ื˜ื™ืŸ ืœื‘ืจื™ืื•ืช ื”ื›ืœืœื™ืช ืฉืœ ื”ืœื‘. ืžื™ื ื•ืŸ ืžื•ืžืœืฅ: 500 ืขื“ 3,000 ืž"ื’ ืœื™ื•ื. 

PQQ (ืคื™ืจื•ืœื•-ืงื•ื•ื™ื ื•ืœื™ืŸ ืงื•ื•ื™ื ื•ืŸ) 

PQQ ืžืกื™ื™ืข ืœื‘ืจื™ืื•ืช ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”. ืžื—ืงืจ ืฉืคื•ืจืกื ื‘-2010 ื‘ื›ืชื‘ ื”ืขืช Journal of Biological Chemistry ื”ื•ื›ื™ื— ืฉืชื•ืกืฃ ื—ืฉื•ื‘ ื–ื” ื™ื›ื•ืœ ืœืกื™ื™ืข ืœื™ืฆื™ืจืช ืื‘ืจื•ื ื™ ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ื—ื“ืฉื™ื ื‘ืชืื™ื, ืžื” ืฉื”ืžื“ืขื ื™ื ืžื›ื ื™ื ื‘ื™ื•ื’ื ื–ื” (biogenesis). ื‘ืงื™ืฆื•ืจ, PQQ ืžืขื ื™ืง ืœื’ื•ืฃ ืืช ื”ื™ื›ื•ืœืช ืœื”ื™ื•ืช “ืื ืจื’ื˜ื™” ื™ื•ืชืจ. ื‘ื ื•ืกืฃ, PQQ ืขืฉื•ื™ ืœืกื™ื™ืข ื‘ื”ื’ื ื” ืขืœ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ืžืคื ื™ ื ื–ืง ื—ืžืฆื•ื ื™, ื›ืš ืงื•ื‘ืข ื“"ืจ ืœื™ ืงื ื• (Lee Know) ื‘ืกืคืจื• ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ื•ืขืชื™ื“ ื”ืจืคื•ืื”.

ืžื—ืงืจ ืฉืคื•ืจืกื ื‘-2013 ื‘ื›ืชื‘ ื”ืขืช The Journal of Nutritional Biochemistry ื”ืจืื” ื›ื™ PQQ ืขืฉื•ื™ ืœืกื™ื™ืข ื‘ื”ืคื—ืชืช ื“ืœืงืช ื‘ื’ื•ืฃ. ื”ื”ื•ื›ื—ื•ืช ืœื›ืš ื”ื™ื• ืจืžื•ืช ื ืžื•ื›ื•ืช ื™ื•ืชืจ ืฉืœ CRP (ื—ืœื‘ื•ืŸ ืžื’ื™ื‘ C) ื•ืฉืœ IL-6 (ืื™ื ื˜ืจืœื•ื™ืงื™ืŸ 6) ื‘ื’ื•ืฃ, ื•ื›ืŸ ืฉื™ื ื•ื™ื™ื ื ื•ืกืคื™ื ืฉื”ืฆื‘ื™ืขื• ืขืœ ืฉื™ืคื•ืจ ื‘ื‘ืจื™ืื•ืช ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”. ืžืืžื™ื ื™ื ื’ื ื›ื™ ื”ื•ื ืขืฉื•ื™ ืœืกื™ื™ืข ื‘ื”ื’ื ื” ืขืœ ื”ืžื•ื— ื•ืžืขื ื™ืง ื™ืชืจื•ื ื•ืช ืื ื˜ื™ ืื™ื™ื’'ื™ื ื’ ื ื•ืกืคื™ื. ืฉื•ืงื•ืœื“ ืžืจื™ืจ ื”ื•ื ืžืงื•ืจ ื˜ื•ื‘ ืœ-PQQ. ืžื™ื ื•ืŸ ืžื•ืžืœืฅ ืœืชื•ืกืฃ: 10 ืขื“ 40 ืž"ื’ ืœื™ื•ื. 

D-ืจื™ื‘ื•ื– (D-ribose)

ื›ื“ืื™ ืœืกืคื•ืจื˜ืื™ื ืœืฉืงื•ืœ ืœืฆืจื•ืš ืืช ื”ืกื•ื›ืจ ื”ื—ืฉื•ื‘ ื”ื–ื” ืœืคื ื™ ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ื•ืื—ืจื™ื”. ืœืžืจื•ืช ืฉD-ืจื™ื‘ื•ื– ืงืฉื•ืจ ืœืžื•ืœืงื•ืœืช ืกื•ื›ืจ, ืžื™ื ื•ื ื™ื ื’ื‘ื•ื”ื™ื ืฉืœื• ื‘ื˜ื•ื—ื™ื ืœืกื•ื‘ืœื™ื ืžืกื•ื›ืจืช ื•ืื™ื ื ืžืฉืคื™ืขื™ื ืขืœ ืจืžื•ืช ื”ืกื•ื›ืจ ื‘ื“ื. D-ืจื™ื‘ื•ื– ืขืฉื•ื™ ืœืกื™ื™ืข ืœืื‘ืจื•ื ื™ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ืœื™ื™ืฆืจ ืื ืจื’ื™ื”, ื›ืš ืขื•ืœื” ืžืžื—ืงืจ ืฉืคื•ืจืกื ื‘-2008 ื‘ื›ืชื‘ ื”ืขืช Journal of Dietary Supplements. ื ื™ืชืŸ ืœื™ื˜ื•ืœ ื‘ืื•ืคืŸ ื‘ื˜ื•ื— ืžื™ื ื•ืŸ ืžื™ื ื™ืžืœื™ ืฉืœ 500 ืž"ื’. ืขื ื–ืืช, ืœืื ืจื’ื™ื” ืžื™ื˜ื‘ื™ืช, ื—ืœืง ืžื”ืžืฉืชืžืฉื™ื ื ื•ื˜ืœื™ื ื‘ื™ืŸ 3 ืœ-5 ื’ืจืžื™ื ืœื™ื•ื. 

ื•ื™ื˜ืžื™ืŸ C

ื•ื™ื˜ืžื™ืŸ C, ื”ื™ื“ื•ืข ื’ื ื‘ืฉืžื•ืช ื—ื•ืžืฆื” ืืกืงื•ืจื‘ื™ืช ื•"ืืกืงื•ืจื‘ื˜", ื”ื™ื” ืื—ื“ ื”ื•ื•ื™ื˜ืžื™ื ื™ื ื”ื ื—ืงืจื™ื ื‘ื™ื•ืชืจ ื‘-50 ื”ืฉื ื™ื ื”ืื—ืจื•ื ื•ืช. ื—ื™ืคื•ืฉ ื‘ืกืคืจื•ืช ื”ืžื“ืขื™ืช ืžื’ืœื” ื›ื™ ืžืื– 1968 ื‘ื•ืฆืขื• ืœืžืขืœื” ืž-53,000 ืžื—ืงืจื™ื ืฉื—ืงืจื• ืืช ื”ื•ื•ื™ื˜ืžื™ืŸ. ืžื”ืžืžืฆืื™ื ืฉืœื”ื ืขื•ืœื” ื›ื™ ื”ื•ื ืžืกื™ื™ืข ืœืงื™ื“ื•ื ืžืขืจื›ืช ื—ื™ืกื•ืŸ ื—ื–ืงื”, ื‘ืจื™ืื•ืช ื”ืœื‘ ื•ื›ืœื™ ื”ื“ื, ื”ืžื•ื— ื•ื”ืขื•ืจ, ื•ืžืขื ื™ืง ื™ืชืจื•ื ื•ืช ืจื‘ื™ื ื ื•ืกืคื™ื. 

ืขืœ ืคื™ ืžื—ืงืจ ืฉืคื•ืจืกื ื‘-2009 ื‘ื›ืชื‘ ื”ืขืช American Journal of Clinical Nutrition, ืืฆืœ ืœืžืขืœื” ืž-7% ืžืื ืฉื™ื ื‘ื’ื™ืœืื™ 6 ื•ืžืขืœื” ืฉื“ืžื ื ื‘ื“ืง ื”ืชื’ืœื” ืžื—ืกื•ืจ ื‘ื•ื•ื™ื˜ืžื™ืŸ C. ื™ื•ืชืจ ืžืžื—ืฆื™ืช ืžื”ื ืกืงืจื™ื ืฆืจื›ื• ื›ืžื•ื™ื•ืช ื ืžื•ื›ื•ืช ืฉืœ ืžื–ื•ืŸ ืขืฉื™ืจ ื‘ื•ื•ื™ื˜ืžื™ืŸ C. 

ื•ื™ื˜ืžื™ืŸ C ื”ื•ื ื ื•ื’ื“ ื—ืžืฆื•ืŸ ืจื‘ ืขื•ืฆืžื” ื”ืžืกื™ื™ืข ืœื”ื‘ื˜ื™ื— ื›ื™ ืื‘ืจื•ื ื™ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ืžืชืคืงื“ื™ื ื›ืจืื•ื™. ืจืžื•ืช ื ืื•ืชื•ืช ืฉืœ ื”ื•ื•ื™ื˜ืžื™ืŸ ื“ืจื•ืฉื•ืช ืœื’ื•ืฃ ื›ื“ื™ ืœื™ื™ืฆืจ L-ืงืจื ื™ื˜ื™ืŸ. ืžื™ื ื•ืŸ ืžื•ืžืœืฅ: ื›ืžื•ืกื•ืช/ื˜ื‘ืœื™ื•ืช ื•ื™ื˜ืžื™ืŸ C – 250 ืž"ื’ ืขื“ 2,000 ืž"ื’ ืœื™ื•ื, ืื‘ืงืช ื•ื™ื˜ืžื™ืŸ C - 250 ืž"ื’ ืขื“ 2,000 ืž"ื’ ืœื™ื•ื, ืื• ืกื•ื›ืจื™ื•ืช ื’ื•ืžื™ ืฉืœ ื•ื™ื˜ืžื™ืŸ C - 250 ืž"ื’ ืขื“ 2,000 ืž"ื’ ืœื™ื•ื

ืงื‘ื•ืฆืช ื”ื•ื•ื™ื˜ืžื™ื ื™ื B ื•ื‘ืจื™ืื•ืช ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”

ืจื™ื‘ื•ืคืœื‘ื™ืŸ (ื•ื™ื˜ืžื™ืŸ B2) 

ืจื™ื‘ื•ืคืœื‘ื™ืŸ ื—ืฉื•ื‘ ืžืื•ื“ ืœื‘ืจื™ืื•ืช ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”. ืจื™ื‘ื•ืคืœื‘ื™ืŸ ื“ืจื•ืฉ ืขื‘ื•ืจ ืื ื–ื™ืžื™ื ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื™ื ื—ืฉื•ื‘ื™ื ื›ืžื• FMN ื•-FAD. “ืงื•ืคืงื˜ื•ืจื™ื” ืืœื• ื“ืจื•ืฉื™ื ืœืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ืœื™ื™ืฆื•ืจ ืžื•ืœืงื•ืœืช ื”ืื ืจื’ื™ื” ATP. 

ืจื™ื‘ื•ืคืœื‘ื™ืŸ ื ื“ืจืฉ ืœืขื™ื›ื•ืœ ื ืื•ืช ืฉืœ ื—ืœื‘ื•ื ื™ื, ืฉื•ืžื ื™ื ื•ืคื—ืžื™ืžื•ืช. ืจื™ื‘ื•ืคืœื‘ื™ืŸ ืขื•ื–ืจ ืœื”ืžื™ืจ ืืช ื—ื•ืžืฆืช ื”ืืžื™ื ื• ื˜ืจื™ืคื˜ื•ืคืŸ ืœื•ื•ื™ื˜ืžื™ืŸ B3 (ื ื™ืืฆื™ืŸ) ื”ืžืกื™ื™ืข ื‘ื”ืคืขืœืช ื•ื™ื˜ืžื™ืŸ B-6. ืื ืฉื™ื ื”ืกื•ื‘ืœื™ื ืžืžื—ืœื•ืช ื›ื‘ื“, ืืœื›ื•ื”ื•ืœื™ื–ื, ืžื—ืœื•ืช ื›ืœื™ื•ืช ื•ืฉืœืฉื•ืœ ื›ืจื•ื ื™ ื ืžืฆืื™ื ื‘ืกื™ื›ื•ืŸ ืœืžื—ืกื•ืจ ื‘ืจื™ื‘ื•ืคืœื‘ื™ืŸ, ื›ืš ืขื•ืœื” ืžืžื—ืงืจ ืฉื ืขืจืš ื‘-2019 ื‘ื›ืชื‘ ื”ืขืช Journal of Inherited Metabolic Disease. Journal of Inherited Metabolic Diseases.

ื•ื™ื˜ืžื™ืŸ B3 (ื ื™ืืฆื™ืŸ)

ื•ื™ื˜ืžื™ืŸ B3ืงื™ื™ื ื‘ืฉืชื™ ืฆื•ืจื•ืช ืฉื•ื ื•ืช - ื”ืจืืฉื•ื ื” ื”ื™ื ื ื™ืืฆื™ืŸ (ื”ืžื›ื•ื ื” ื’ื ื—ื•ืžืฆื” ื ื™ืงื•ื˜ื™ื ื™ืช), ื•ื”ืฉื ื™ื™ื” ื”ื™ื ื ื™ืืฆื™ื ืžื™ื“ (ื”ื™ื“ื•ืขื” ื’ื ื‘ืฉื ื ื™ืงื•ื˜ื™ืŸ). ืฉืชื™ ื”ืฆื•ืจื•ืช ืžื”ื•ื•ืช ืงื•ื“ืžืŸ (precursor) ืœื ื™ืงื•ื˜ื™ื ืืžื™ื“ ืื“ื ื™ืŸ ื“ื™ื ื•ืงืœืื•ื˜ื™ื“ (NAD), ื”ืžืžืœื ืชืคืงื™ื“ ื—ืฉื•ื‘ ื‘ื‘ืจื™ืื•ืช ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”. 

ื ื™ืืฆื™ืŸ ืžืขื•ืจื‘ ื›ืงื•ืคืงื˜ื•ืจ ื‘ื™ื•ืชืจ ืž-400 ืชื’ื•ื‘ื•ืช ื‘ื™ื•ื›ื™ืžื™ื•ืช ื‘ื’ื•ืฃ, ื•ืขื•ื–ืจ ื‘ืขื™ืงืจ ื‘ื—ื™ืœื•ืฃ ื—ื•ืžืจื™ื ืฉืœ ืื ืจื’ื™ื”. ื ื™ืืฆื™ืŸ ืขื•ื–ืจ ืœื”ืžืจืช ืžื–ื•ืŸ ืœืื ืจื’ื™ื” ื•ืžืกื™ื™ืข ื‘ืชื™ืงื•ืŸ ืฉืœ ื”-DNA. 

ืžื—ืกื•ืจ ื‘ื•ื•ื™ื˜ืžื™ืŸ ืขืœื•ืœ ืœื’ืจื•ื ืœื›ืš ืฉืœื ื ื•ื›ืœ ืœืคืจืง ืคื—ืžื™ืžื•ืช, ื—ืœื‘ื•ื ื™ื ืื• ืฉื•ืžื ื™ื. ื ื™ืืฆื™ืŸ ืžื•ืžืจ ืขืœ ื™ื“ื™ ื”ื’ื•ืฃ ืœ-NAD, ืžื•ืœืงื•ืœื” ืคืขื™ืœื” ื—ืฉื•ื‘ื” ื”ืžืกื™ื™ืขืช ืœืชืคืงื•ื“ ืชืงื™ืŸ ืฉืœ ื’ื•ืฃ ื”ืื“ื. 

ื•ื™ื˜ืžื™ืŸ B5 (ื—ื•ืžืฆื” ืคื ื˜ื•ืชื ื™ืช)

ื•ื™ื˜ืžื™ืŸ ืžืกื™ืก ื‘ืžื™ื ื–ื” ื”ื•ื ื—ื•ืžืจ ืžื–ื™ืŸ ื—ื™ื•ื ื™ ื”ื“ืจื•ืฉ ืœื‘ื™ืฆื•ืข ืกื™ื ืชื–ื” ืฉืœ ืงื• ืื ื–ื™ื A, ื•ื›ืŸ ืขื‘ื•ืจ ืชื”ืœื™ืš ื—ื™ืœื•ืฃ ื”ื—ื•ืžืจื™ื ืฉืœ ืฉื•ืžื ื™ื, ืคื—ืžื™ืžื•ืช ื•ื—ืœื‘ื•ื ื™ื. ื”ื•ื ื“ืจื•ืฉ ื’ื ื›ื“ื™ ืœืกื™ื™ืข ืœื—ื•ืžืฆื•ืช ืฉื•ืžื ื™ื•ืช ืœื”ื™ื›ื ืก ืœืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”. ืžื—ืงืจ ืžืฉื ืช 1996 ื”ืจืื” ื›ื™ ื•ื™ื˜ืžื™ืŸ B5 ื™ื›ื•ืœ ืœืกื™ื™ืข ื‘ื”ื’ื ื” ืขืœ ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ืžืคื ื™ ื ื–ืง ื—ืžืฆื•ื ื™.

ื•ื™ื˜ืžื™ืŸ B6 (ืคื™ืจื™ื“ื•ืงืกื™ืŸ)

ืœื•ื•ื™ื˜ืžื™ืŸ B6 ื™ืชืจื•ื ื•ืช ื‘ืจื™ืื•ืชื™ื™ื ืจื‘ื™ื, ื”ื—ืœ ื‘ืžื ื™ืขืช ืกื™ื‘ื•ื›ื™ื ืกื•ื›ืจืชื™ื™ื ื•ืขื“ ืœื”ืื˜ืช ืชื”ืœื™ืš ื”ื”ื–ื“ืงื ื•ืช ื•ืžื ื™ืขืช ืžื—ืœื•ืช ืœื‘. ืขืœ ืคื™ ืžื—ืงืจ ืฉื ืขืจืš ืขืœ ื‘ืขืœื™ ื—ื™ื™ื ื‘ืฉื ืช 1981, ืขื“ 20 ืื—ื•ื– ืžื”ื›ืžื•ืช ืฉืœ ื•ื™ื˜ืžื™ืŸ B6 ื ืžืฆืืช ื‘ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”, ื•ืœื›ืŸ ืื™ ืืคืฉืจ ืœื”ื˜ื™ืœ ืกืคืง ื‘ื—ืฉื™ื‘ื•ืชื• ืœื‘ืจื™ืื•ืช ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”. ืžื—ืงืจ ืžืฉื ืช 2006 ื”ื•ื›ื™ื— ื’ื ืฉื•ื•ื™ื˜ืžื™ืŸ B6 ืžืžืœื ืชืคืงื™ื“ ื—ืฉื•ื‘ ื‘ืกื™ื•ืข ืœืžื™ื˜ื•ื›ื•ื ื“ืจื™ื” ืœื™ื™ืฆืจ ื ื•ื’ื“ื™ ื—ืžืฆื•ืŸ ื”ืžื’ื™ื ื™ื ืขืœื™ื”ื.

ื‘ืจื–ืœ

ื‘ืจื–ืœ ื”ื•ื ืื—ื“ ื”ืžื™ื ืจืœื™ื ื”ื ืคื•ืฆื™ื ื‘ื™ื•ืชืจ ื‘ื’ื•ืคื ื•. ื”ื’ื•ืฃ ืžืฉืชืžืฉ ื‘ื• ื›ื“ื™ ืœื™ื™ืฆืจ ื”ืžื•ื’ืœื•ื‘ื™ืŸ, ื”ื—ืœื‘ื•ืŸ ื”ืขื™ืงืจื™ ื‘ื“ื ื”ืžืขื‘ื™ืจ ื—ืžืฆืŸ ืœื›ืœ ืคื™ื ื” ื‘ื’ื•ืฃ. ืจืžื•ืช ื ืžื•ื›ื•ืช ืฉืœ ื‘ืจื–ืœ ืขืœื•ืœื•ืช ืœื’ืจื•ื ืœื›ืš ืฉื”ื’ื•ืฃ ืœื ื™ื•ื›ืœ ืœื™ื™ืฆืจ ืชืื™ ื“ื ืื“ื•ืžื™ื ืฉืžื—ืกื•ืจ ื‘ื”ื ืขืœื•ืœ ืœื’ืจื•ื ืœืื ืžื™ื” ื•ื›ืชื•ืฆืื” ืžื›ืš ืœืขื™ื™ืคื•ืช. ืื ืจืžืช ื”ื‘ืจื–ืœ ื ืžื•ื›ื”, ื—ืฉื•ื‘ ืœืคื ื•ืช ืœืจื•ืคื ืฉื™ื‘ื“ื•ืง ืžื” ื”ืกื™ื‘ื” ืœื›ืš. 

ืขืœ ืคื™ ืืจื’ื•ืŸ ื”ื‘ืจื™ืื•ืช ื”ืขื•ืœืžื™ (WHO), ืžื—ืกื•ืจ ื‘ื‘ืจื–ืœ ื”ื•ื ืื—ืช ื”ื”ืคืจืขื•ืช ื”ืชื–ื•ื ืชื™ื•ืช ื”ื ืคื•ืฆื•ืช ื‘ื™ื•ืชืจ ื‘ืขื•ืœื. ื”ื”ืขืจื›ื” ื”ื™ื ื›ื™ ืžื—ืกื•ืจ ื‘ื‘ืจื–ืœ ื”ื•ื ื”ื’ื•ืจื ืœ-50 ืื—ื•ื– ืžืžืงืจื™ ื”ืื ืžื™ื” ื‘ืจื—ื‘ื™ ื”ืขื•ืœื. ืžื—ืกื•ืจ ื‘ื‘ืจื–ืœ ืฉื›ื™ื— ื™ื•ืชืจ ืืฆืœ ื ืฉื™ื (ื‘ื’ืœืœ ื”ืžื—ื–ื•ืจ ื”ื—ื•ื“ืฉื™) ืžืืฉืจ ืืฆืœ ื’ื‘ืจื™ื.

ื‘ืฉื ื™ื ื”ืื—ืจื•ื ื•ืช ื”ืชื‘ืจืจ ื›ื™ ื‘ืจื–ืœ ื—ืฉื•ื‘ ื’ื ืœื‘ืจื™ืื•ืช ื”ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”. ืžื™ื ืจืœ ื”ื‘ืจื–ืœ ื ื—ื•ืฅ ืœืชืคืงื•ื“ื ื”ืชืงื™ืŸ ืฉืœ ืจื‘ื™ื ืžื”ืื ื–ื™ืžื™ื ืฉื‘ืžื™ื˜ื•ื›ื•ื ื“ืจื™ื”, ืžื” ืฉืžืกื‘ื™ืจ ื›ื›ืœ ื”ื ืจืื” ืžื ื’ื ื•ืŸ ื ื•ืกืฃ ืฉื‘ื’ืœืœื• ืจืžื” ื ืžื•ื›ื” ืฉืœ ื‘ืจื–ืœ ืขืœื•ืœื” ืœืชืจื•ื ืœืขื™ื™ืคื•ืช, ื’ื ื›ืืฉืจ ืœื ืžื“ื•ื‘ืจ ื‘ืื ืžื™ื”. ืœืขื™ืชื™ื ืงืจื•ื‘ื•ืช ืจื•ืคืื™ื ืžื‘ืฆืขื™ื ื‘ื“ื™ืงืช ื“ื ืœืžื“ื™ื“ืช ืจืžืช ื”ืคืจื™ื˜ื™ืŸ ื‘ื“ื ืžื›ื™ื•ื•ืŸ ืฉืจืžื” ื ืžื•ื›ื” ืฉืœื• ืขืœื•ืœื” ืœื”ืฆื‘ื™ืข ืขืœ ืžื—ืกื•ืจ ื‘ื‘ืจื–ืœ. ื”ืจืžื•ืช ื”ืื•ืคื˜ื™ืžืœื™ื•ืช ื”ืŸ 50 ng/ml, ืืคื™ืœื• ื‘ื”ื™ืขื“ืจ ืื ืžื™ื”. ืœืกืคื™ื’ื” ืžื™ื˜ื‘ื™ืช, ืžื•ืžืœืฅ ืœื™ื˜ื•ืœ ื‘ืจื–ืœ ื‘ืฉื™ืœื•ื‘ ืขื ืชื•ืกืฃ ื•ื™ื˜ืžื™ืŸ C

ื”ืคื ื™ื•ืช:

  1. Hagen TM, Liu J, Lykkesfeldt J, et al. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress [published correction appears in Proc Natl Acad Sci U S A 2002 May 14;99(10):7184]. Proc Natl Acad Sci U S A. 2002;99(4):1870–1875. doi:10.1073/pnas.261708898
  2. Ann N Y Acad Sci. 2002 Apr;959:491-507. (L-carnitine and heart health)
  3. J Nutr Biochem. 2013 Dec;24(12):2076-84. doi: 10.1016/j.jnutbio.2013.07.008.
  4. Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):10836-10844. doi: 10.1073/pnas.1809045115. Epub 2018 Oct 15.
  5. Herrick J, St Cyr J. Ribose in the heart. J Diet Suppl. 2008;5:213–217. doi: 10.1080/19390210802332752
  6. American Journal of Clinical Nutrition. 2009 Nov;90(5):1252-63. doi: 10.3945/ajcn.2008.27016. Epub 2009 Aug 12.
  7. Balasubramaniam S, Christodoulou J, Rahman S. Disorders of riboflavin metabolism. J. Inherit. Metab. Dis. 2019 Jan 24;
  8. Free Radic Biol Med. 1996;20(6):793-800.
  9. https://www.sciencedirect.com/science/article/pii/S0891584903006099
  10. J Biol Chem. 1981 Jun 25;256(12):6041-6.